{"id":210191,"date":"2017-08-06T03:15:12","date_gmt":"2017-08-06T07:15:12","guid":{"rendered":"http:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/edap-tms-nasdaqedap-and-photomedex-phmd-head-to-head-analysis-bnb-daily-blog\/"},"modified":"2017-08-06T03:15:12","modified_gmt":"2017-08-06T07:15:12","slug":"edap-tms-nasdaqedap-and-photomedex-phmd-head-to-head-analysis-bnb-daily-blog","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/tms\/edap-tms-nasdaqedap-and-photomedex-phmd-head-to-head-analysis-bnb-daily-blog\/","title":{"rendered":"Edap Tms (NASDAQ:EDAP) and PhotoMedex (PHMD) Head to Head Analysis &#8211; BNB Daily (blog)"},"content":{"rendered":"<p><p>    Edap Tms (NASDAQ: EDAP) and PhotoMedex (NASDAQ:PHMD) are both    small-cap medical companies, but which is the better stock? We    will compare the two businesses based on the strength of their    dividends, institutional ownership, risk, analyst    recommendations, profitabiliy, earnings and valuation.  <\/p>\n<p>    Institutional & Insider Ownership  <\/p>\n<p>    8.0% of Edap Tms shares are held by institutional investors.    Comparatively, 5.2% of PhotoMedex shares are held by    institutional investors. 22.4% of PhotoMedex shares are held by    insiders. Strong institutional ownership is an indication that    large money managers, hedge funds and endowments believe a    company is poised for long-term growth.  <\/p>\n<p>    Earnings & Valuation  <\/p>\n<p>    This table compares Edap Tms and PhotoMedexs gross revenue,    earnings per share and valuation.  <\/p>\n<p>    Edap Tms has higher revenue and earnings than PhotoMedex.  <\/p>\n<p>    Risk & Volatility  <\/p>\n<p>    Edap Tms has a beta of 0.98, meaning that its stock price is 2%    less volatile than the S&P 500. Comparatively, PhotoMedex    has a beta of 0.74, meaning that its stock price is 26% less    volatile than the S&P 500.  <\/p>\n<p>    Analyst Ratings  <\/p>\n<p>    This is a breakdown of current ratings for Edap Tms and    PhotoMedex, as provided by MarketBeat.  <\/p>\n<p>    Edap Tms presently has a consensus price target of $7.00,    suggesting a potential upside of 137.29%. Given Edap Tms    higher possible upside, equities analysts plainly believe Edap    Tms is more favorable than PhotoMedex.  <\/p>\n<p>    Profitability  <\/p>\n<p>    This table compares Edap Tms and PhotoMedexs net margins,    return on equity and return on assets.  <\/p>\n<p>    Summary  <\/p>\n<p>    Edap Tms beats PhotoMedex on 10 of the 11 factors compared    between the two stocks.  <\/p>\n<p>    About Edap Tms  <\/p>\n<p>    EDAP TMS S.A. (EDAP) is a holding company engaged    in developing and marketing the Ablatherm and Focal One    devices. The Company operates two divisions: High Intensity    Focused Ultrasound (HIFU) and Urology Devices and Services    (UDS) (including lithotripsy activities). The Company is    developing HIFU technology for the treatment of certain other    types of tumors. The Company also produces and commercializes    medical equipment for treatment of urinary tract stones using    extra-corporeal shockwave lithotripsy (ESWL) and distributes    other types of urology devices in certain countries. The HIFU    division is engaged in the development, manufacturing and    marketing of medical devices based on HIFU technology for the    invasive treatment of urological and other clinical    indications. The UDS division is engaged in the development,    marketing, manufacturing and servicing of medical devices for    the invasive diagnosis or treatment of urological disorders,    urinary stones, and other clinical indications.  <\/p>\n<p>    About PhotoMedex  <\/p>\n<p>    PhotoMedex, Inc. is a global health products and    services company providing integrated disease management and    solutions to dermatologists, professional aestheticians and    consumers. The Company provides products and services that    address skin diseases and conditions, including acne and photo    damage. The Company operates through three business segments:    Consumer segment, Physician Recurring segment and Professional    segment. The Company provides skin health solutions to spa    markets, as well as traditional retail, online and infomercial    outlets for home-use products. The Companys Consumer segment    is engaged in the designing, development, manufacturing and    selling of long-term hair reduction and acne consumer products.    Its Physician Recurring segment is engaged in the sales of    skincare products. Its Professional segment is engaged in the    sale of equipment, such as medical and esthetic light and heat    based products. Its LHE brands includes Mistral, Kona, FSD,    SpaTouch Elite and accessories.  <\/p>\n<p>    Receive News & Ratings for Edap Tms S.A.    Daily - Enter your email address below to receive a    concise daily summary of the latest news and analysts' ratings    for Edap Tms S.A. and related companies with     MarketBeat.com's FREE daily email newsletter.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Excerpt from:<\/p>\n<p><a target=\"_blank\" rel=\"nofollow\" href=\"https:\/\/www.baseball-news-blog.com\/2017\/08\/06\/head-to-head-review-photomedex-phmd-edap-tms-nasdaqedap-updated.html\" title=\"Edap Tms (NASDAQ:EDAP) and PhotoMedex (PHMD) Head to Head Analysis - BNB Daily (blog)\">Edap Tms (NASDAQ:EDAP) and PhotoMedex (PHMD) Head to Head Analysis - BNB Daily (blog)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Edap Tms (NASDAQ: EDAP) and PhotoMedex (NASDAQ:PHMD) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitabiliy, earnings and valuation.  <a href=\"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/tms\/edap-tms-nasdaqedap-and-photomedex-phmd-head-to-head-analysis-bnb-daily-blog\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[187756],"tags":[],"class_list":["post-210191","post","type-post","status-publish","format-standard","hentry","category-tms"],"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/210191"}],"collection":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/comments?post=210191"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/210191\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/media?parent=210191"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/categories?post=210191"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/tags?post=210191"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}